A monoclonal antibody against human FXYD6

Hybridoma

Volumn 30, Issue 5, 2011, Pages 487-490

  Liu, Jungui ^a   Zhou, Ningxin ^a   Zhang, Xiaodong ^a  

^a General Hospital of the Second Artillery   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FXYD6 PROTEIN; FXYD6 PROTEIN MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY; SYNTHETIC PEPTIDE; TUMOR PROTEIN; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY ISOLATION; ANTIBODY PRODUCTION; ANTIBODY TITER; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HYBRIDOMA CELL CULTURE; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; CELL MEMBRANE; HUMANS; HYBRIDOMAS; IMMUNOGLOBULIN G; ION CHANNELS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PANCREATIC NEOPLASMS;

MUS;

EID: 80054976328     PISSN: 15540014     EISSN: 15578348     Source Type: Journal    
DOI: 10.1089/hyb.2011.0039     Document Type: Article

References (21)

1. Zhang XD, Zhou NX, Lu BS, Jia XH, and Huang PT: Differentially expressed genes of cholangiocarcinoma tissues. Dig Surg 2002;1:13-15.
2. Wan T, Ni B, Liu JW, Ye L, and Zhou NX: Cloning and identification of a novel CCR-L2/FXYD6 gene related to cholangiocarcinoma. Chin J Exp Surg 2003;20:393-395.
3. Xiao M, Zhou NX, Gao LJ, Zhang AQ, Guo W, Zhang XD, and Wan T: A study on expression of human gene fxyd6 in bile duct benign and malignant tumors by RT-PCR. J He-patobil Surg 2007;15:223-224.
4. Xiao M, Zhou NX, Gao LJ, Zhang AQ, Guo W, Gao YB, Peng RY, Zhang XD, and Wan T: Semi-quantitative analysis for human fxyd6 gene of cholangiocarcinoma. Chin J Bases Clin General Sur 2008;15:83-85.
5. Dou CQ, Yue X, and Zhou NX: Effect of human antisense-FXYD6 on proliferation and invasion of human cholangio-carcinoma cells in vitro. Shi Jie Hua Ren Xiao Hua Za Zhi 2007;15:929-935. (Pubitemid 46953034)
6. Kohler G, and Milstein C: Continuous cultures of fused cells secreting antibody of predefined specificity. 1975. J Immunol 2005;174:2451-2452.
7. Widegren E, Onnesjo S, Arbman G, Kayed H, Zentgraf H, Kleeff J, Zhang H, and Sun XF: Expression of FXYD3 protein in relation to biological and clinicopathological variables in colorectal cancers. Chemotherapy 2009;55:407-413.
8. Loftas P, Onnesjo S, Widegren E, Adell G, Kayed H, Kleeff J, Zentgraf H, and Sun XF: Expression of FXYD-3 is an independent prognostic factor in rectal cancer patients with preoperative radiotherapy. Int J Radiat Oncol Biol Phys 2009;75:137-142.
9. Arimochi J, Ohashi-Kobayashi A, and Maeda M: Interaction of Mat-8 (FXYD-3) with Na/K-ATPase in colorectal cancer cells. Biol Pharm Bull 2007;30:648-654. (Pubitemid 46570978)
10. Okudela K, Yazawa T, Ishii J, Woo T, Mitsui H, Bunai T, Sakaeda M, Shimoyamada H, Sato H, Tajiri M, Ogawa N, Masuda M, Sugimura H, and Kitamura H: Down-regulation of FXYD3 expression in human lung cancers: its mechanism and potential role in carcinogenesis. Am J Pathol 2009;175: 2646-2656.
11. Yamamoto H, Okumura K, Toshima S, Mukaisho K, Sugihara H, Hattori T, Kato M, and Asano S: FXYD3 protein involved in tumor cell proliferation is overproduced in human breast cancer tissues. Biol Pharm Bull 2009;32:1148-1154.
12. Grzmil M, Voigt S, Thelen P, Hemmerlein B, Helmke K, and Burfeind P: Up-regulated expression of the MAT-8 gene in prostate cancer and its siRNA-mediated inhibition of expression induces a decrease in proliferation of human prostate carcinoma cells. Int J Oncol 2004;24:97-105.
13. Gordon GJ, Richards WG, Sugarbaker DJ, Jaklitsch MT, and Bueno R: A prognostic test for adenocarcinoma of the lung from gene expression profiling data. Cancer Epidemiol Biomarkers Prev 2003;12:905-910. (Pubitemid 37151527)
14. Iacobuzio-Donahue CA, Maitra A, Olsen M, Lowe AW, van Heek NT, Rosty C, Walter K, Sato N, Parker A, Ashfaq R, Jaffee E, Ryu B, Jones J, Eshleman JR, Yeo CJ, Cameron JL, Kern SE, Hruban RH, Brown PO, and Goggins M: Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am J Pathol 2003;162:1151-1162. (Pubitemid 36350660)
15. Izumi T, Oda Y, Hasegawa T, Nakanishi Y, Iwasaki H, So-nobe H, Goto H, Kusakabe H, Takahira T, Kobayashi C, Kawaguchi K, Saito T, Yamamoto H, Tamiya S, Iwamoto Y, and Tsuneyoshi M: Prognostic significance of dysadherin expression in epithelioid sarcoma and its diagnostic utility in distinguishing epithelioid sarcoma from malignant rhabdoid tumor. Mod Pathol 2006;9:820-831. (Pubitemid 43780452)
16. Muramatsu H, Akimoto T, Maebayashi K, Kita M, and Mitsuhashi N: Prognostic significance of dysadherin and E-cadherin expression in patients with head and neck cancer treated by radiation therapy. Anticancer Res 2008;28:3859-3864.
17. Kyzas PA, Stefanou D, Batistatou A, Agnantis NJ, Nakanishi Y, Hirohashi S, and Charalabopoulos K: Dysadherin expression in head and neck squamous cell carcinoma: association with lymphangiogenesis and prognostic significance. Am J Surg Pathol 2006;30:185-193. (Pubitemid 43740187)
18. Shimamura T, Yasuda J, Ino Y, Gotoh M, Tsuchiya A, Na-kajima A, Sakamoto M, Kanai Y, and Hirohashi S: Dysad-herin expression facilitates cell motility and metastatic potential of human pancreatic cancer cells. Cancer Res 2004; 64:6989-6995. (Pubitemid 39331008)
19. Yamaguchi F, Yamaguchi K, Tai Y, Sugimoto K, and Tokuda M: Molecular cloning and characterization of a novel phos-pholemman-like protein from rat hippocampus. Brain Res Mol Brain Res 2001;86:189-192. (Pubitemid 32124773)
20. George AJ, Gordon L, Beissbarth T, Koukoulas I, Holsinger RM, Perreau V, Cappai R, Tan SS, Masters CL, Scott HS, and Li QX: A serial analysis of gene expression profile of the Alzheimer's disease Tg2576 mouse model. Neurotox Res 2009;16.
21. Ito Y, Nakamura Y, Takahashi N, Saito S, Aleksic B, Iwata N, Inada T, and Ozaki N: A genetic association study of the FXYD domain containing ion transport regulator 6 (FXYD6) gene, encoding phosphohippolin, in susceptibility to schizophrenia in a Japanese population. Neurosci Lett 2008;438:70-75.